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Abstract
1. The underlying mechanisms involved in the adaptive regulation of b-amino acid uptake in the human proximal tubule
 .were examined by use of an immortalized human embryonic kidney epithelial cell line IHKE . 2. The results indicated that
the adaptive response to maintain whole-body taurine homeostasis occurs predominantly via changes in the activity of the
high-affinity taurine transport system by alterations in the uptake capacity and with an unaffected half-saturation constant.
An adaptive response was not observed for the structurally related b-alanine. 3. Only colchicine, which interferes with
microtubule organization, was capable of blocking the response to alterations of taurine in cell medium, whereas inhibition
of protein and nucleic acid synthesis by cycloheximide and actinomycin D, respectively, did not change the adaptive
 .pattern. 4. Phorbol 12-myristate 13-acetate PMA , mimicking the effects of diacylglycerol, induced inhibition of both
b-alanine and taurine uptake. By contrast, the Ca2q-ionophore A23187, mimicking the effects of IP , only stimulated the3
uptake of taurine but not the influx of b-alanine. However, the effect of PMA down-regulation and A23187 up-regulation
was rapid and short-lived in contrast to the adaptive response, suggesting that the inositol phospholipid pathway involving
diacetylglycerol and IP is less likely to be linked directly to the adaptive regulation, but rather plays a role in short-term3
regulation.
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1. Introduction
The adaptive response of the renal tubules to
dietary change have been studied with increasing
interest the past ten to twenty years. Among the
amino acids investigated, especially the b-amino acid
taurine has received considerable attention. Taurine is
Abbreviations: IHKE, immortalized human kidney epithelial
 .cell line embryonic ; NHKE, normal human kidney epithelial
 .cell line embryonic, primary culture ; Hepes, N-2-hydroxyethyl-
X piperazine-N -2-ethanesulphonic acid; M ES, 2- N -
.morpholino ethanesulphonic acid; FCS, fetal calf serum
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the major free intracellular amino acid in most mam-
malian tissue and seems to play an important physio-
logical role by being implicated as an agent in, e.g.,
bile acid conjugation, osmoregulation, membrane
protection, calcium modulation, antioxidation, and
 w x.detoxification for further details see Refs. 1–3 .
Substantial evidence indicates that this amino acid is
a conserved metabolite and that the whole body
homeostasis in mammals is regulated by changes in
 .the activity of b-amino acid transport system s lo-
cated in luminal membranes of renal proximal tubule
w x4–9 . Thus, the renal tubular epithelium is able to
increase the uptake of taurine during periods of low
dietary intake and vice versa.
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Previous reports concerning the renal handling of
taurine have been based mainly on experiments using
w x w xrenal cortex slices 1,10 , isolated renal tubules 11,12
w xand filtration techniques 4,6,13–19 . However, in the
past years, there has been an increasing focus on the
use of epithelial cell cultures because of its suitability
to study cellular regulation of amino acid transport
under well-defined conditions. Especially the LLC-
PK cell line, which is derived from proximal tubule1
of pig kidney, have been examined in detail in regard
to the renal reabsorption of taurine. Thus, it was
initially shown that the uptake of taurine into conflu-
ent monolayers of LLC-PK cells was mediated by a1
single, b-amino acid specific transport component
highly dependent upon Naq and Cly. It was demon-
strated that the LLC-PK cells exhibited the same1
adaptive response to alterations in cell medium con-
centrations of taurine as mentioned above by chang-
 .ing the uptake capacity V rather than the appar-max
ent K for taurine and without changes in aminom
w xacid efflux 5 . Addition of cycloheximide or
colchicine to the cell medium prevented the increase
of taurine influx in response to taurine-free medium,
whereas actinomycin D had no effect. Treatment of
the LLC-PK cell monolayers with phorbol 12-myri-1
state 13-acetate and phorbol 12,13-dibutyrate reduced
the taurine uptake, and this inhibitory effect could be
blocked with staurosporin, indicating the involvement
w xof protein kinase C 20 . However, a recent study
concerning the polarity of taurine transport in the
LLC-PK cell line showed that in contrast to previ-1
ous reports the uptake of amino acid occurs by two
Naq-dependent transport components at both the lu-
w xminal and basolateral surfaces 21 . This raises the
question whether it is only the activity of the high-af-
finity carrier or both systems, which is up-regulated
at low dietary intake of taurine. Moreover, even
though the LLC-PK cell line has retained several1
characteristics of the proximal tubule, the LLC-PK1
cells in contrast to normal kidney cells have almost
 . qno parathyroidea hormone PTH receptors, the Na -
dependent phosphate uptake is not controlled by PTH
or cAMP and a transport component for
cystinerlysine seems to be absent.
Recently, we have characterized an immortalized
 .human embryonic kidney epithelial cell line IHKE ,
which exhibits microvilli and enzymes specific for
the proximal tubule. We have shown that this cell
line has retained the capacity and specificity to trans-
port a-amino isobutyric acid by comparing results
with those found in normal human embryonic kidney
 . w xepithelial cells NHKE 22 . The uptake of taurine
and b-alanine was characterized by two Naq-depen-
dent transport components, and competition experi-
ments revealed that taurine and b-alanine drastically
reduced the uptake of one another by the high-affin-
ity transport system. Further investigation of the
high-affinity taurine carrier revealed a specific re-
quirement for Cly with a probable coupling ratio of 3
Naqr1 Clyr1 amino acid and preliminary experi-
ments indicated that the IHKE cell line also up-regu-
lates the influx of taurine in response to taurine-free
w xcell medium 23 . Comparison of the results obtained
 .  .for normal NHKE and immortalized IHKE em-
bryonic cells with those obtained for primary cell
cultures from proximal tubule of human adults
 .AHKE suggested an unaltered expression of the
types of transport carriers for neutral a-and b-amino
acids. However, the results also indicated a relative
increase in the uptake capacity of the above-men-
tioned transport proteins during maturation, which
may explain, at least partly, the phenomenon of
physiologic amino aciduria in neonates for further
w x.details, see Ref. 24 .
Thus, the purpose of the present study was to
examine the underlying mechanisms involved in the
adaptive regulation of taurine uptake in the human
proximal tubule by use of the IHKE cell line. We
demonstrate that it is predominantly the activity of
the high-affinity transport component, which is in-
creased in the presence of a taurine-free cell medium
and that a similar response is absent for the struc-
turally related b-alanine. Furthermore, the role of
protein and nucleic acid synthesis, microtubule orga-
nization, and the two branches of the inositol phos-
pholipid signalling pathway were examined by addi-
tion of specific pharmacological agents to human
kidney cells.
2. Materials and methods
2.1. Materials
w 3 x1,2- H taurine was purchased from Amersham and
w 3  .xb- 3- H N alanine was obtained from Dupont, NEN
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 .research Products Boston, MA . Fetal calf serum
 .FCS , growth medium, transferrin and antibiotics
 .were from Gibco, NY, USA. Hydrocortisone H0135 ,
 .  .epidermal growth factor E-4127 , insulin I-1882 ,
 .  .phorbol 12-myristate 13-acetate PMA P-8139 ,
 .  .4a-phorbol 12,13-didecanoate PDD P8014 , the
 .calcium ionophore A23187 C-7522 , cycloheximide
 .  .C-6255 , colchicine C-9754 , actinomycin D
 .  .  .A1410 , taurine T-0625 , and b-alanine A-7752
were obtained from Sigma Chemical Co. St. Louis,
.MO, USA . All other reagents were of the highest
purity available.
2.2. Cell culture
IHKE cells were kindly provided by Dr. Aage
Haugen, Department of Toxicology, National Insti-
tute of Occupational Health, Oslo, Norway, and grown
in Dulbecco’s MEM with glutamax containing 1% of
FCS. The medium was supplemented with epidermal
 y5 .  y3 .growth factor 10 grl , insulin 5=10 grl ,
 y5 .  y3hydrocortisone 4=10 grl , transferrin 5=10
.  2 .grl , 2 mM glutamine, penicillin 10 IUrl and
 y1 .  y3streptomycin 1=10 grl and Na SeO 5=102 3
.  .grl . The cultures were grown at 378C pH 7.4 in an
atmosphere of 5% CO in air.2
2.3. Transport studies
Uptake studies were performed on monolayers in
 .35-mm single dishes NUNC, Denmark as soon as
the cells had obtained confluence. Transport of tau-
rine and b-alanine was measured by the following
techniques: 24 h before each experiment taurine or
b-alanine was added to the cell medium, reaching a
final concentration of 0, 50 or 500 mM unless other-
wise stated. After removal of medium, each dish was
washed twice at 378C with 2 ml Earle’s Balanced
 .Salt Solution EBSS , containing 5 mM D-glucose
 .pH 7.4 , and incubated for 90 min with the same
solution in order to minimize any trans-effects due to
the intracellular pool of amino acids. They were then
incubated with 0.75 ml of incubation medium con-
 .taining EBSS pH 7.4, 378C , radiolabelled ligand
and other constituents as required. The incubation
was terminated after 30 min by aspiration of the
incubation media and immediately washing the cells
 .three times with 2 ml ice-cold EBSS pH 7.4 . After
removal of the last volume of the ice-cold stop
solution, 0.6 ml of 1% SDS in 0.2 N NaOH was
added to solubilize the cells. The radioactivity in the
cells was determined by withdrawal of three samples
of 0.1 ml, which were counted in a liquid scintillation
counter Packard Tri-carb liquid scintillation ana-
.lyzer after addition of 3 ml scintillation fluid. Cor-
rection for non-specific uptake was made in control
experiments by estimating the amount of radiola-
belled taurine retained in the extracellular space or
bound to the cell surface after incubation with ice-cold
incubation medium. Thus, these parallel experiments
were performed in exactly the same way as the other
experiments with the only exception that the incuba-
tion medium, kept on ice, was added to the Petri
dishes for 10 s before withdrawal and the cells were
three times with ice-cold stop solution. All uptake
studies were performed in an atmosphere of 5% CO2
in air and the EBSS were supplemented with 15 mM
 .HepesrKOH pH 7.4 in order to stabilize extracellu-
lar pH.
The amount of total cell protein was determined by
the method of Lowry et al. with bovine serum albu-
 .min Sigma Chemical Co., St. Louis, MO, USA as a
standard. All solutions in this study were sterilized
before use.
2.4. Calculations
Kinetics: The results of the saturation experiments
were analyzed by Michaelis-Menten kinetics accord-
ing to the following equation:
V S V Smax1 max2Uptakes q
K q S K q Sm1 m2
where K represents the substrate concentration thatm
gives half-maximal uptake, V denotes maximalmax
w xrate and S indicates the concentration of substrate in
the medium. Index 1 and 2 refer to the first and a
second transport system, respectively. In the case
w xwhere K 4 S , the equation is simplified to:m2
V Smax1Uptakes qP S
K q Sm1
where P is a constant. This equation incorporates one
transport system in parallel with a non-enzymatic
leak mechanism. Theoretical saturation curves were
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fitted to the experimental data by using a computer-
w xanalyzed statistical iteration procedure 25 .
3. Results
Initially, we examined whether or not taurine star-
vation up-regulates the activity of both the high and
low affinity taurine transport systems in the IHKE
cell line. To do so, we measured the kinetics of
taurine uptake after the cells had been incubated in
cell media containing 0, 50 or 500 mM taurine 24 h
prior to addition of increasing concentrations of radi-
 .olabelled taurine for details see Section 2 . The
results are shown in Fig. 1A, where it is seen that the
lower the taurine concentration in the cell medium
the higher the radiolabelled taurine uptake is at a
given taurine concentration. In all three cases, the
kinetic analyses of the data indicate the presence of
more than one transport component. On the assump-
tion that 50 mM taurine reflects the physiological
level of amino acid, the results in Fig. 1B are given
as the uptakes obtained by starved cells 0 mM
.taurine relatively to the uptakes found for the non-
 .starved cells 50 mM taurine . The hyperbolic curve
clearly indicates that the increased amino acid uptake
is caused predominantly by an up-regulation in the
activity of the high affinity transport component.
Since numerous studies have indicated that the renal
uptake of taurine occurs by a specific b-amino acid
w xtransport component 13,18,19,26,27 , similar experi-
ments were carried out in which the radiolabelled
taurine was replaced by the structurally related b-
alanine. By contrast to results shown in Fig. 1B, the
absence of b-alanine in the cell medium for 24 h did
not affect the uptake of radiolabelled b-alanine within
 .the concentration range studied Fig. 1C . Nor did
incubation of the IHKE cells in cell media containing
0, 50 or 500 mM taurine result in any increase in the
uptake of radiolabelled b-alanine.
Fig. 1. Kinetics of taurine and b-alanine uptake by IHKE cells
 .preincubated with taurine or b-alanine. A Monolayers of IHKE
 .  .  .cells were preincubated with 0 ‘ , 50 v and 500 I mM
 .taurine for 24 hrs for further details, see Section 2 . The cells
w 3 xwere incubated in EBSS, 40 nM 1,2- H taurine and various
 .concentrations of unlabelled taurine ranging from 0–1.0 mM. B
The uptake of taurine illustrated as the uptake ratio between cells
 .preincubated with 0 mM and 50 mM taurine for 24 h. C The
uptake of b-alanine illustrated as the uptake ratio between cells
 .preincubated with 0 mM and 50 mM b-alanine ‘ or with 0
 .mM and 50 mM taurine v for 24 h. Uptake was measured as
wdescribed above substituting taurine with 109 nM b 3-
3  .xH N alanine and various concentrations of unlabelled b-alanine
ranging from 0–1.0 mM. The results given are the mean values"
S.D. of four experiments. In those cases where vertical bars are
absent, S.D. were smaller than graphical representation of the
mean.
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Table 1 shows the kinetic constants for the high
affinity taurine transport system found by computer
w xanalysis 25 of the uptake data given in Fig. 1A. The
half-saturation constants K are almost identical inm1
all three cases, whereas there seems to be a tendency
of increasing the uptake capacity of amino acid in the
absence of taurine in the cell medium. The calculated
 .constants for the low affinity system s could not be
Table 1
Kinetic parameters for the uptake of taurine by IHKE cells
preincubated with 0, 50 and 500 mM taurine
 .   .Taurine mM V nmolr30 min K mMmax1 max1
.per mg protein
0 4.28"1.57 10.4"3.29
50 2.50"1.59 14.9"8.43
500 2.30"0.94 12.7"10.74
The kinetic constants for the high affinity taurine transport
system were determined by computer-analysed statistical iteration
w xprocedure 25 of the uptake data given in Fig. 1A.
determined satisfactorily because of the lack of satu-
 .ration of the transport component s over the concen-
tration range studied. Calculations using the one-
transport one-leak model resulted in exactly the same
kinetic parameters as those given in Table 1 and the
standard deviation of the fit was identical to the one
found for the two site model.
In order to further examine the adaptive response
regarding the renal handling of taurine, a series of
experiments was performed in which the cell mono-
layers were pretreated with either actinomycin D,
cycloheximide, or colchicine. The results are shown
in Fig. 2, where the uptakes are given as percentage
of the taurine influx measured in IHKE cells incu-
bated in cell media containing 50 mM taurine desig-
.nated as 100% . Actinomycin D, which inhibits nu-
cleic acid synthesis transcription and chain elonga-
.tion , did not affect the adaptive phenomenon, al-
though actinomycin D in general reduced the uptake
 .of taurine Fig. 2A . Exactly the same picture
emerged, when cycloheximide, inhibiting the protein
synthesis by binding to the 80-s ribosome, substituted
 .actinomycin D in the pretreatment period Fig. 2B .
Fig. 2. Effect of actinomycin D, cycloheximide and colchicine on
 .the uptake of taurine. A IHKE cell monolayers were preincu-
bated for 2 h with and without addition of actinomycin D 0.5
.  .  .  .  .mgrml , B cycloheximide 0.1 mM or C colchicine 50 mM
to the cell medium containing 0, 50 or 500 mM taurine. The
uptake was measured as described in Section 2 and the media
w 3 xcontained 255–700 nM 1,2- H taurine and sufficiently unla-
belled taurine to reach a total concentration of 1 mM. The
uptakes are given in percentage of taurine influx measured in
 .cells preincubated in media containing 50 mM taurine 100% .
Solid bars without inhibitors, hatched bars with inhibitors. Re-
sults are given as mean values of at least 3 determinations"S.D.
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Increasing the concentration of cycloheximide from
0.1 mM to 70 mM and actinomycin D from 0.5
mgrml to 50 mgrml did not alter the pattern apart
from an increase in the general reduction of taurine
 .influx results not shown . By contrast, colchicine
had a marked effect on the adaptive response to
changes in the taurine concentration in the cell
medium. Colchicine binds specifically to tubulin and
interferes with microtubule organization, depolarizes
the microtrabecular network and prevents protein ex-
ocytosis but not endocytosis. The data illustrated in
Fig. 2C show that addition of colchicine results in
almost identical uptake values at the cell medium
concentration of 0, 50 and 500 mM taurine. Thus, the
adaptive response at low taurine concentrations is no
longer observed.
We also investigated the role of the inositol phos-
pholipid pathway in order to determine if protein
kinase C or Ca2qrcalmodulin kinases are involved in
the signal pathway of adaptive regulation of the
uptake of b-amino acids in IHKE cells. The two
branches of the inositol phospholipid pathway are
based on the cleaving of PIP to diacylglycerol and2
IP . Since the effects of diacylglycerol can be mim-3
icked by phorbol esters, we examined the effect of
 .phorbol 12-myristate 13-acetate PMA on the activ-
ity of the b-amino acid transporter in the IHKE cell
line. Thus, PMA is a highly potent tumor promoter
w xcapable of activating protein kinase C 28 . The cell
 .monolayers were treated with PMA 100 nM for 20
to 120 min before addition of radiolabelled amino
acid. For comparison, we also studied the effect of
treating the monolayers with 4a-phorbol 12,13-dide-
 .canoate PDD , which even though it is an analogue
w xto PMA, is unable to activate protein kinase C 29,30 .
Since stock solutions of the phorbol esters contained
 .dimethyl sulphoxide DMSO , control experiments
were carried out in which cell monolayers were
treated with equal concentrations of DMSO but with-
out phorbol esters. We found that the concentration
of DMSO used in the present study did not affect the
uptake of amino acid under these conditions results
.not shown . Fig. 3A illustrates that treatment of the
IHKE cells with PMA, in contrast to PDD, reduced
the uptake of taurine with a maximal inhibition of 60
min. Hereafter, the effect of PMA diminished and the
amino acid uptake at 120 min has almost reached the
same level as the uptake of taurine in the presence of
Fig. 3. Time course of the effect of PMA and PDD on the uptake
of taurine and b-alanine. The IHKE cells were preincubated for
20–120 min in EBSS containing 5 mM D-glucose and 100 nM
 .  .  .PMA v or PDD ‘ . A The uptake medium contained 255
w 3 xnM 1,2- H taurine, 1 mM taurine and 100 nM PMA or PDD and
 . w 3  .xB 72 nM b 3- H N alanine, 1 mM b-alanine and 100 nM
PMA or PDD. Each point is defined by at least 3 determinations
"S.D. In those cases where vertical bars are absent, standard
deviations are smaller than the graphical representation of the
mean.
PDD. Similar results were obtained by replacing
radiolabelled taurine with equivalent amount of b-
alanine as illustrated in Fig. 3B. Thus, our results
indicate that the PMA-induced inhibition of the b-
amino acid transport is caused by the involvement of
protein kinase C since PDD had no effect on the
amino acid uptake. However, the effect of PMA was
rapid and short-lived as compared to the adaptive
response seen by starved cells.
An attempt to investigate the effect of changes in
the cytosolic free calcium concentration on b-amino
acid uptake was also done since the effects of IP in3
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the inositol phospholipid pathway can be mimicked
by using a Ca2q ionophore allowing Ca2q to move
from the extracellular fluid into the cytosol. Thus, we
evaluated the effect of the Ca2q ionophore A23187
by comparing the uptakes of amino acid in the pres-
ence with the uptakes in the absence of A23187. The
results for taurine are given in Fig. 4A, where the
increase in ratio indicates a stimulation in the taurine
uptake, which is maximal after an incubation time of
 .20 min approx. 30% enhancement . Thereafter, the
effect of the Ca2q ionophore decreases approaching
the normal influx level after 60 min, indicating that
the effect of A23187 is rapid and relatively short-lived
Fig. 4. Time course of the effect of the calcium ionophore
A23187 on the uptake of taurine and b alanine. The IHKE cells
were preincubated for 0–60 min in EBSS containing 5 mM
 .D-glucose with and without 0.2 mM A23187. A The uptake
w 3 xmedium contained 255 nM 1,2- H taurine, 1 mM taurine and
 .0.2 mM A23187. B The uptake medium contained 72 nM
w 3  .xb 3- H N alanine, 1 mM b-alanine and 0.2 mM A23187. Re-
sults are given as mean values"S.D. of triplicates.
compared to the response obtained by starvation. By
contrast, as seen from Fig. 4B, A23187 did not
enhance the uptake of b-alanine, but rather decreased
it. Thus, the amino acid influx in the presence of
A23187 was only 0.7 times the uptakes in the ab-
sence of Ca2q ionophore found after 60 min of
incubation.
4. Discussion
Our findings indicate that the adaptive response to
maintain whole-body taurine homeostasis occurs pre-
dominantly via the high-affinity taurine carrier even
though the amino acid uptake may be mediated by
more than one Naq-dependent transport system. Fur-
thermore, the data given in Table 1 suggest that the
adaption of membrane function is accompanied by
 .changes in the uptake capacity V , whereas themax
 .half-saturation constant K is unaffected. The samem
pattern has previously been reported for the LLC-PK1
cell line and the K -value for the high-affinity com-m
ponent in these cells is identical to the one found in
w xthe present study for the IHKE cells 20 . Thus, these
findings indicate that the adaptive response to changes
in dietary taurine intake is the result of alterations in
the number of active or available taurine carriers in
the cell membrane. Since it is generally agreed that
the influx of taurine and b-alanine at low substrate
concentrations occurs via a b-amino acid-specific
transport system, as also reported for the IHKE cell
w xline 23 , we examined the effect of depleting the cell
medium of taurine or b-alanine on the uptake of
b-alanine. However, no adaptive response was found
under these conditions, emphasizing the importance
of the sulfonate group in taurine versus the carboxyl-
ate group in b-alanine. Thus, although taurine and
b-alanine have similarities, both having a positive
and negative charge, there is a profound difference in
the negative character of the carboxylate group com-
pared to the sulfonate group.
In order to gain further insight in the mechanisms
involved in the adaptive response, monolayers of
IHKE cells were exposed to actinomycin D, cyclo-
heximide, or colchicine before addition of radiola-
belled taurine. Only colchicine, which interferes with
microtubule organization and prevents protein exocy-
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tosis but not endocytosis, was capable of blocking the
response to alterations of taurine in cell medium. By
contrast, Jones and co-workers studying LLC-PK1
cells could only demonstrate an effect of the agent in
the presence of taurine-free medium but not on the
w xresponse to high-medium taurine 20 . Inhibition of
RNA transcription with actinomycin D did not affect
the adaptive response of taurine influx in the IHKE
cell line, which is in accordance with previous results
w xregarding LLC-PK -cells 20 . On the other hand,1
inhibiting the protein synthesis with cycloheximide
did not change the adaptive pattern of taurine uptake
in the human cells, whereas similar experiments with
LLC-PK cells showed a marked effect on the re-1
sponse to taurine-free as well as taurine-high medium
w x20 . The discrepancy between the two cell lines is
not known at present but variations in speciesrcell
lines cannot be excluded.
We also examined the influence of the inositol
phospholipid pathway on the uptake of b-amino
acids in the IHKE cell line. Addition of PMA which
activates protein kinase C by mimicking the effect of
the physiologically diacylglycerols inhibited the up-
take of both taurine and b-alanine in a time-depen-
dent manner, reaching a maximum after 60 min.
After 60 min, the influx of b-amino acid increased,
indicating a reversible effect of PMA. Results from
similar experiments with LLC-PK cells and the hu-1
man colon carcinoma cell line HT-29 showed that
PMA had an inhibitory effect on the activity of the
transport of taurine and both b-amino acids, respec-
w xtively 20,31 . Addition of the isomer PDD, which is
unable to activate the protein kinase C, did not affect
the uptake of b-amino acids in the IHKE cell line.
Nor did PDD reduce the uptake of amino acid in
w xHT-29 cells 31 . Investigators have speculated
whether or not the protein kinase C leads to phospho-
rylation of the taurine carrier, thereby inactivating the
w xcarrier 31 . This may be supported by the fact that
the effect of PMA observed in the present study
occurred relatively quickly and peaked after only 60
min. Exactly the same observation makes the theory
that the enzyme may block the transcription andror
translation mechanisms, thereby inhibiting the syn-
thesis of taurine carriers, less likely. Another hypoth-
esis may be that protein kinase C reduces the trans-
w xmembrane gradients of sodium and chloride 31 .
Jones and co-workers have demonstrated that PMA
increased taurine efflux from LLC-PK cell monolay-1
w xers, whereas PDD had no effect 20 . By contrast, the
authors also reported in another study that the differ-
ences in uptake found after manipulation of medium
taurine concentrations were not associated with
w xchanges in taurine efflux in the LLC-PK cells 5 .1
The fact that PDD in contrast to PMA failed to alter
the uptake of b-amino acids seems to indicate the
involvement of protein kinase C in a short-term, rapid
regulation of b-amino acid influx. Accordingly, PMA
induced inhibition of both b-alanine and taurine up-
take even though, in the present study, we could only
demonstrate an adaptive regulation for the influx of
taurine and not of b-alanine.
Since numerous studies have demonstrated that the
influx of taurine and the structurally related b-alanine
is mediated by the same specific b-amino acid trans-
port system at low substrate concentrations, we antic-
ipated that the Ca2q ionophore A23187 mimicking
the effects of IP had similar effect on the uptake of3
both these amino acids. However, surprisingly, the
A23187 only stimulated the transport of taurine tran-
siently, whereas the uptake of b-alanine was unaf-
fected. The reason for the discrepancy of the effect of
A23187 on the uptake of the two b-amino acids is
not clear. Thus, even though we observed a similar
pattern for the adaptive response, suggesting that the
complex regulation is more dependent on
Ca2qrcalmodulin kinases rather than protein kinase
C, there is a considerable time gap between the two
phenomena, indicating that the pathway involving IP3
is more likely to play a role in a short-term, rapid
regulation of taurine uptake.
Taken together, the regulation of the high-affinity
taurine transporter in the human IHKE cell line was
affected by colchicine, indicating that transport of
preformed carriers into the cell membrane may play
an important part in the adaptive response to low
dietary intake of taurine. Furthermore, the phe-
nomenon of PMA down-regulation and A23187 up-
regulation of taurine uptake was rapid and short-lived
in contrast to the adaptive response. Consequently, it
seems less likely that the inositol phospholipid path-
way involving diacylglycerols and IP is linked di-3
rectly to the adaptive regulation, but rather plays a
role in short-term regulation. However, an additional
long-term, indirect effect cannot be excluded at pre-
sent and needs to be further elucidated in the future.
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